NCT05477654

Brief Summary

Neuromuscular dysfunction is common in older adults and even more pronounced in neurodegenerative diseases. In Parkinson's disease (PD), a complex set of factors often prevents effective performance of activities of daily living that require intact and simultaneous performance of motor and cognitive tasks. In the current study we aim at employing the Mobile Brain/Body Imaging approach (MoBI) to gain further insides of neuromuscular biomarkers revealing the decrements of older adults with an early PD. The cross-sectional study will be evaluated through the multifactorial mixed-measure design.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Aug 2022

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 26, 2022

Completed
2 days until next milestone

First Posted

Study publicly available on registry

July 28, 2022

Completed
4 days until next milestone

Study Start

First participant enrolled

August 1, 2022

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2023

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 30, 2023

Completed
Last Updated

August 1, 2022

Status Verified

July 1, 2022

Enrollment Period

1 year

First QC Date

July 26, 2022

Last Update Submit

July 27, 2022

Conditions

Outcome Measures

Primary Outcomes (3)

  • dual-task costs while walking

    Test for dual-task costs associated with the concurrent execution of overground walking and a secondary cognitive task

    Day 1

  • dual-task costs while standing

    Test for dual-task costs associated with the concurrent execution of semi-tandem stance and a secondary cognitive task

    Day 1

  • dual-task costs while execution of isometric task

    Test for dual-task costs associated with the concurrent execution of isometric contraction and a secondary cognitive task

    Day 1

Secondary Outcomes (1)

  • The Movement Disorder Society Unified Parkinson's Disease Rating Scale (MDS-UPDRS)

    Day 1

Study Arms (2)

Parkinson's disease patients

Patients with an early diagnosis of Parkinson's disease

Diagnostic Test: Extensive motor-cognitive testing protocol

Healthy controls

Healthy controls who are age-matched

Diagnostic Test: Extensive motor-cognitive testing protocol

Interventions

Screening of their functional performance while monitoring brain and muscle activity

Healthy controlsParkinson's disease patients

Eligibility Criteria

Age50 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study population will include healthy age-matched controls and patients with an early diagnosis of Parkinson's disease.

You may qualify if:

  • no diagnosis of cognitive or movement disorder,
  • score \> 7 for the Short Physical Performance Battery (SPPB),
  • living independently in the community,
  • age range between 55 and 70 years,
  • no color blindness.
  • diagnosed according to the last MDS criteria (2015),
  • duration of the disease less than 5 years,
  • positive DATSCAN,
  • diagnosed akinetic-rigid or mixed phenotype,
  • score of 1 or maximally 2 on the Hoehn and Yahr scale (Hoehn \& Yahr, 1967),
  • MoCA score ≥ 24 points,
  • score \> 7 for the SPPB,
  • age range between 50 and 75 years,
  • no color blindness
  • living independently in the community.

You may not qualify if:

  • advanced stages of PD (Hoehn and Yahr score \> 2)
  • any acute or chronic diseases, especially of the peripheral and central nervous system, heart failure, respiratory failure, severe osteoarthritis, and major psychiatric illness such as depression
  • MoCA score \< 24 points,
  • severe disabling tremor,
  • recurrent falls,
  • impaired vision that is not corrected with e.g., glasses,
  • low SPPB score

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Science and research centre Koper

Koper, 6000, Slovenia

Location

Related Publications (1)

  • Marusic U, Peskar M, Somen MM, Kalc M, Holobar A, Gramann K, Wollesen B, Wunderlich A, Michel C, Miladinovic A, Catalan M, Buoite Stella A, Ajcevic M, Manganotti P. Neuromuscular assessment of force development, postural, and gait performance under cognitive-motor dual-tasking in healthy older adults and people with early Parkinson's disease: Study protocol for a cross-sectional Mobile Brain/Body Imaging (MoBI) study. Open Res Eur. 2023 Nov 10;3:58. doi: 10.12688/openreseurope.15781.3. eCollection 2023.

MeSH Terms

Conditions

Parkinson DiseaseMotor DisordersCognitive Dysfunction

Condition Hierarchy (Ancestors)

Parkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative DiseasesMental DisordersCognition DisordersNeurocognitive Disorders

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate professor

Study Record Dates

First Submitted

July 26, 2022

First Posted

July 28, 2022

Study Start

August 1, 2022

Primary Completion

August 1, 2023

Study Completion

October 30, 2023

Last Updated

August 1, 2022

Record last verified: 2022-07

Data Sharing

IPD Sharing
Will not share

Locations